1859

1859

Verified
Biotechnology company focusing on the discovery and development of next-generation therapeutics.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$160—240m (Dealroom.co estimates Feb 2022.)
San Diego California (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

$0.0

round
N/A

$0.0

round
N/A

$0.0

round
*

$40.0m

Series A
Total Funding000k

Recent News about 1859

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.